Insulin resistance in lean and overweight non-diabetic Caucasian adults: Study of its relationship with liver triglyceride content, waist circumference and BMI
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
AIMS: Insulin resistance is the pathophysiological precursor of type 2 diabetes mellitus (DM-2), and its relationship with non-alcoholic fatty liver disease (NAFLD) has been widely studied in patients with obesity or metabolic syndrome using not only ultrasound but also liver biopsies or proton magnetic resonance spectroscopy (H1-MRS) to assess liver fat content. In contrast, there are no studies on insulin resistance and NAFLD in lean or overweight Caucasian individuals using H1-MRS or liver biopsies for the quantification of hepatic triglyceride content. Our objectives were to study the presence of insulin resistance in lean and overweight Caucasian adults and investigate its possible relationship with liver triglyceride content, waist circumference (as proxy of visceral adiposity), BMI, and cardiometabolic risk factors. METHODS: A cross-sectional study was conducted in 113 non-obese, non-diabetic individuals classified as overweight (BMI 25-29.9 kg/m2) or lean (BMI 19.5-24.9 kg/m2). Hepatic triglyceride content was quantified by 3T H1-MRS. NAFLD was defined as hepatic triglyceride content >5.56%. Insulin resistance (HOMA-IR), serum adiponectin, and tumor necrosis factor (TNF) were determined. RESULTS: HOMA-IR was significantly correlated with hepatic triglyceride content (r:0.76; p<0.0001). The lean-with-NAFLD group had significantly higher HOMA-IR (p<0.001) and lower serum adiponectin (p<0.05) than the overweight-without-NAFLD group. Insulin resistance was independently associated with NAFLD but not with waist circumference or BMI. Regression analysis showed hepatic triglyceride content to be the most important determinant of insulin resistance (p<0.01). CONCLUSIONS: Our findings suggest that NAFLD, once established, seems to be involved in insulin resistance and cardio-metabolic risk factors above and beyond waist circumference and BMI in non-obese, non-diabetic Caucasian individuals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Lean individuals can be insulin-resistant and, conversely, people with obesity can be insulin-sensitive without an increased risk of future diabetes or cardiovascular disease.96”
From Definition and diagnostic criteria of clinical obesity (2025) · cites this paper as [96]
Experimental — accuracy not yet measuredIn the citing paper
“Subcutaneous adipose tissue (SAT) releases the majority of circulating FFAs, but visceral adipose tissue (VAT), although it is smaller than SAT, is highly lipolytic 13, and the FFAs from VAT are released directly into the portal vein and taken up mainly by the liver on their first pass.14,15”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [15]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664
Vernon, G., Baranova, A., & Younossi, Z. M. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04724.x · Cited by 3,074
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
Targher, G., Day, C. P., & Bonora, E. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0912063 · Cited by 1,907
Szczepaniak, L. S., Nurenberg, P., Leonard, D., Browning, J. D., Reingold, J. S., Grundy, S., Hobbs, H. H., & Dobbins, R. L. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00064.2004 · Cited by 1,562
Adams, L. A., Anstee, Q. M., Tilg, H., & Targher, G. (2017) · Gut · doi:10.1136/gutjnl-2017-313884 · Cited by 1,174
Beyond insulin resistance in NASH: TNF-α or adiponectin?
Hui, J. M., Hodge, A., Farrell, G. C., Kench, J. G., Kriketos, A., & George, J. (2004) · Hepatology · doi:10.1002/hep.20280 · Cited by 942
Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy
Reeder, S. B., Cruite, I., Hamilton, G., & Sirlin, C. B. (2011) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.22580 · Cited by 822
Cited by
Definition and diagnostic criteria of clinical obesity
Rubino, F., Cummings, D. E., Eckel, R. H., Cohen, R. V., Wilding, J. P. H., Brown, W. A., Stanford, F. C., Batterham, R. L., Farooqi, I. S., Farpour-Lambert, N. J., et al. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00316-4 · Cited by 1,811
Lipid metabolism in MASLD and MASH: From mechanism to the clinic
Carli, F., Della Pepa, G., Sabatini, S., Vidal Puig, A., & Gastaldelli, A. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2024.101185 · Cited by 147
A review of non‐alcoholic fatty liver disease in non‐obese and lean individuals
Ahadi, M., Molooghi, K., Masoudifar, N., Namdar, A. B., Vossoughinia, H., & Farzanehfar, M. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15353 · Cited by 107
Lean NAFLD: an underrecognized and challenging disorder in medicine
Maier, S., Wieland, A. C., Cree‐Green, M., Nadeau, K. J., Sullivan, S. A., Lanaspa, M. A., Johnson, R. J., & Jensen, T. (2021) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09621-1 · Cited by 85
“Cantero, 2018 [99] Granada, Spain Compared to lean without NAFLD, more likely male, greater waist circumference, liver enzymes, and IR.”
BackgroundSensitivity to Thyroid Hormone Indices Are Closely Associated With NAFLD
Lai, S., Li, J., Wang, Z., Wang, W., & Guan, H. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.766419 · Cited by 73
Ceylan, H. İ., Saygın, Ö., & Türkçü, Ü. Ö. (2020) · Chronobiology International · doi:10.1080/07420528.2020.1792482 · Cited by 67
Nonalcoholic fatty liver disease in lean subjects: Prognosis, outcomes and management
Chrysavgis, L., Ztriva, E., Protopapas, A. A., Τζιόμαλος, Κ., & Cholongitas, Ε. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i42.6514 · Cited by 54
Metabolic syndrome and its association with nonalcoholic steatohepatitis
Bril, F., Sanyal, A., & Cusi, K. (2023) · Clinics in Liver Disease · doi:10.1016/j.cld.2023.01.002 · Cited by 52
Li, B., Wang, Y., Ye, Z., Yang, H., Cui, X., Wang, Z., & Liu, L. (2018) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/jpps29831 · Cited by 43
Shao, C., Ye, J., Li, F., Feng, S., Wang, W., & Zhong, B. (2019) · Digestive and Liver Disease · doi:10.1016/j.dld.2019.02.019 · Cited by 44
Do, M. H., Oh, M., Lee, H., Kang, C.-H., Yoo, G., & Park, H. (2022) · Nutrients · doi:10.3390/nu14091965 · Cited by 44
Sinn, D. H., Kang, D., Cho, S. J., Paik, S. W., Guallar, E., Cho, J., & Gwak, G.-Y. (2021) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002158 · Cited by 37
Olveira, A., Augustín, S., Benlloch, S., Ampuero, J., Suárez‐Pérez, J. A., Armesto, S., Vilarrasa, E., Belinchón, I., Herranz, P., Crespo, J., et al. (2023) · Life · doi:10.3390/life13020419 · Cited by 44
“However, one of the most significant disadvantages related to MAFLD is that, once it is established, it contributes to insulin resistance and cardio-metabolic risk factors, especially in non-obese, non-diabetic individuals [16].”
BackgroundPatel, A. H., Peddu, D. K., Amin, S., Elsaid, M. I., Minacapelli, C. D., Chandler, T.-M., Catalano, C., & Rustgi, V. K. (2022) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2022.00204 · Cited by 47
Meyer‐Gerspach, A. C., Peterli, R., Moor, M., Madoerin, P., Schötzau, A., Nabers, D., Borgwardt, S., Beglinger, C., Bieri, O., & Wölnerhanssen, B. K. (2019) · Obesity Surgery · doi:10.1007/s11695-019-03897-2 · Cited by 39
Jenkins, B., Ronis, M. J. J., & Koulman, A. (2020) · Metabolites · doi:10.3390/metabo10070296 · Cited by 43
“Work presented by Gonzalez-Cantero and colleagues [28] showed that hepatic triacylglyceride content were correlated with insulin resistance and these relationships were independently to the inflammatory marker TNF α .”
Non alcoholic fatty liver disease and risk of incident diabetes in subjects who are not obese
Sung, K.-C., Seo, D.-C., Lee, S., Lee, M.-Y., Wild, S. H., & Byrne, C. D. (2019) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2019.01.016 · Cited by 32
“A recent study showed that normal weight subjects with NAFLD are more insulin resistant than overweight subjects without NAFLD and that liver fat accumulation may be an important cause of insulin resistance in non-obese subjects with NAFLD [11].”
BackgroundPrevalence and Predictors of Insulin Resistance in Non-Obese Healthy Young Females in Qatar
Elrayess, M. A., Rizk, N. M., Fadel, A., & Kerkadi, A. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17145088 · Cited by 34
Adams, D. M., Reay, W. R., Geaghan, M. P., & Cairns, M. J. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-00847-w · Cited by 31
Rodríguez, J. L. M., Gonzalez-Cantero, J., González‐Cantero, Á., Martí‐Bonmatí, L., Alberich‐Bayarri, Á., Cejudo, M. T. G., & Gonzalez-Calvin, J. L. (2019) · Diabetes & Metabolism · doi:10.1016/j.diabet.2019.01.005 · Cited by 24
Self-citationFetuin-A in Activated Liver Macrophages Is a Key Feature of Non-Alcoholic Steatohepatitis
Etienne, Q., Lebrun, V., Komuta, M., Navez, B., Thissen, J., Leclercq, I. A., & Lanthier, N. (2022) · Metabolites · doi:10.3390/metabo12070625 · Cited by 26
Ren, W., Feng, Y., Feng, Y., Li, J., Zhang, C., Feng, L., Cui, L., & Ran, J. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-023-01775-6 · Cited by 26
Alam, S., Eslam, M., Hasan, S. N., Anam, K., Chowdhury, M. A. B., Khan, M. A. S., Hasan, M. J., & Mohamed, R. B. (2021) · JGH Open · doi:10.1002/jgh3.12658 · Cited by 20
Xu, M., Li, M., Zhang, Y., Li, L., Shen, Y., & Hu, G. (2025) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.70095 · Cited by 19
Aneni, E. C., Bittencourt, M. S., Teng, C., Cainzos‐Achirica, M., Osondu, C. U., Soliman, A., Al-Mallah, M. H., Buddoff, M. J., Parise, E. R., Santos, R. D., et al. (2020) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2020.100097 · Cited by 20
Jahromi, B. N., Borzou, N., Parsanezhad, M. E., Anvar, Z., Ghaemmaghami, P., & Sabetian, S. (2021) · International Journal of Reproductive BioMedicine (IJRM) · doi:10.18502/ijrm.v19i7.9476 · Cited by 18
“Table II presents a comparison of the hormonal profiles according to BMI and five indirect methods of IR.”
BackgroundInfluentialBilić-Čurčić, I., Berković, M. C., Virović-Jukić, L., & Mrzljak, A. (2021) · World Journal of Hepatology · doi:10.4254/wjh.v13.i1.80 · Cited by 14
Ruan, S., Yuan, X., Liu, J., Zhang, Q., & Ye, X. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s441641 · Cited by 10
Predictive Risk Factors of Nonalcoholic Fatty Liver Disease in a Lean Chinese Population
Liu, L., Shi, X., Gao, J., Xu, C., & Liu, X. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12121958 · Cited by 7
“Studies have reported that lean NAFLD subjects had more visceral adiposity, which leads to a high level of FFA in the liver and exacerbates hepatic triglyceride accumulation [26].”
BackgroundFatima, H., Rangwala, H. S., Mustafa, M. S., Shafique, M. A., Abbas, S. R., & Rangwala, B. S. (2024) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188241274310 · Cited by 8
Hashimoto, N., Wakagi, M., Ippoushi, K., & Takano‐Ishikawa, Y. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.06.003 · Cited by 6
Hashimoto, N., Han, K., Wakagi, M., Ishikawa-Takano, Y., Ippoushi, K., & Fukushima, M. (2021) · Nutrition Research · doi:10.1016/j.nutres.2021.05.006 · Cited by 6
Han, X., Kong, J., Zhang, H., Zhao, Y., Zheng, Y., & Wei, C. (2024) · Obesity Facts · doi:10.1159/000536447 · Cited by 6
“IR is the pathophysiological basis of metabolic disorder, further promotes the synthesis of FFAs in liver cells, and reduces very low-density lipoprotein output, forming a vicious circle and aggravating NAFLD [34, 35].”
BackgroundYari, Z., Fotros, D., & Hekmatdoost, A. (2023) · Scientific Reports · doi:10.1038/s41598-023-41893-w · Cited by 36
“NAFLD, independent of other risk factors, is highly associated with an increased risk of metabolic disorders including cardiovascular disease, type 2 diabetes mellitus (T2DM) and metabolic syndrome (MetS) in obese and non-obese individuals 4,5 .”
BackgroundMechanisms of non-alcoholic fatty liver disease development in normal-weight individuals
Muriel, P., Cardoso-Lezama, I., Vargas-Pozada, E. E., & Ramos‐Tovar, E. (2023) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002530 · Cited by 4
Kamani, L., Siddiqui, M., & Rahat, A. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-03790-6 · Cited by 5
“In his research, Gonzalez-Cantero et al. found that the mean HOMA-IR of non-diabetic NAFLD patients was substantially greater than that of healthy controls (6.73 ± 4.0 vs. 2.47 ± 1.04) [21].”
InfluentialHashimoto, N., Nagata, R., Han, K., Wakagi, M., Ishikawa-Takano, Y., & Fukushima, M. (2023) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-023-00987-9 · Cited by 4
“Metabolic syndromes (MetS), with symptoms including dyslipidemia, insulin resistance, hyperuricemia, and hypertension [8, 9, 15, 23, 31, 39], are serious global health issues.”
Ishay, Y., Neutel, J., Kolben, Y., Gelman, R., Arbib, O. S., Lopez, O., Katchman, H., Mohseni, R., Kidron, M., & Ilan, Y. (2023) · Gastro Hep Advances · doi:10.1016/j.gastha.2023.11.016 · Cited by 3
“37,38 In the present study, there was no change in body weight, which is vital as it supports a direct effect of the drug on the disease.”
BackgroundZhang, X., Wang, S., Xu, S., Min, R., Ling, Y., Sun, S., & Gong, R. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s482638 · Cited by 2
Yu, D., Yang, X. Y., Zhang, X., Wang, X., Pu, Z., Mi, A., Ran, L., Zhang, F., Liang, B., & Wu, Y. (2025) · Life Metabolism · doi:10.1093/lifemeta/loaf037 · Cited by 2
“Clinical studies have also shown that lean MAFLD patients exhibit impaired glucose tolerance when compared to lean individuals without MAFLD [5, 33].”
Barbaro, F., Conza, G. D., Quartulli, F. P., Quarantini, E., Quarantini, M., Zini, N., Fabbri, C., Mosca, S., Caravelli, S., Mosca, M., et al. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1374135 · Cited by 2
BARRETO, B. F. D. M., Punaro, G., ELIAS, M. C., & Parise, E. R. (2022) · Arquivos de Gastroenterologia · doi:10.1590/s0004-2803.202203000-72 · Cited by 2
“In this study, when patients were separated according to the presence or absence of IR, the fact that there are no differences in BMI is noteworthy, since in the general population there is a relationship between BMI and HOMA-IR(25), and in NAFLD patients between the degree of steatosis and HOMA-IR(24,25,30).”
BackgroundResultTabassum, F., Devi, N., Panda, S., Padhy, R. K., Dey, P., & Behera, L. (2023) · National Journal of Laboratory Medicine · doi:10.7860/njlm/2023/58015.2703 · Cited by 1
Hyperinsulinemia: Diagnostic and Treatment Considerations
Hunt, C. W., & DeBellis, J. (2022) · Obesity and Diabetes Research · doi:10.47275/2692-0964-118 · Cited by 1
Bakour, N., Duggan, C., & Annett, S. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1008462 · Cited by 1
Severeyn, É., Cruz, A. L., Wong, S., & Perpiñán, G. (2020) · Advances in intelligent systems and computing · doi:10.1007/978-3-030-63665-4_13
Rensing, B. (2021) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8716
Zhu, X., Wang, H., Zhang, H., Nie, G., Yan, J., & Li, X. (2024) · International Journal of Clinical Practice · doi:10.1155/2024/7081486
“Accumulation of visceral fat exposes the liver to high levels of free fatty acids, thus exacerbating the accumulation of TG in the liver [51].”
BackgroundFetuin-A Can Assess the Severity of Alcohol-Related Liver Disease
Salmanoğlu, M., Küçük, İ., & Baş, S. (2025) · Medicina · doi:10.3390/medicina61071147
“…the higher BMI values were noted in the ALD patients, they had lower SFA concentrations compared to the HCs, and as noted earlier, and in light of current data, this result may be possibly due to the insulin-sensitizing effect of ethanol, but further investigations are needed to confirm [12,14,23].”
Insulin Resistance Assessment in Relation to Obesity Levels Among Iraqi Type 2 Diabetics
(2025) · Obesity and Diabetes Research · doi:10.47275/2692-0964-131
Association between serum chemerin and breast cancer mediated by lipid metabolism
Li, H., Xu, Q., Huang, M., Shu, J., Chen, S., Xia, J., Liu, Y., & Ye, Y. (2026) · Discover Oncology · doi:10.1007/s12672-026-05350-0
Islam, K. I., Majumder, I. A., Nira, F. S., Das, G., Azom, S. H. M. S., Hema, H. H., & Ferdaus, F. (2026) · Bangladesh Journal of Food and Nutrition · doi:10.70945/bjfn.v03i01.073
Tao, J., Zhong, Y., Li, H., Wang, W., & Tan, J. (2026) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s557710
Metadata
- Authors
- Gonzalez-Cantero, J., Martin-Rodriguez, J. L., Gonzalez-Cantero, A., Arrebola, J. P., & Gonzalez-Calvin, J. L.
- Affiliations
- Instituto de Investigación Biosanitaria de Granada (ES)
- Corresponding author
- Arrebola, Juan Pedro
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2018-02-09
- Volume
- 13
- Issue
- 2
- Pages
- e0192663
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC5806885
- OpenAlex
- W2787771062
- Cited by
- 51
- References
- 38
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 7 · 2023: 8 · 2022: 5 · 2021: 8 · 2020: 10 · 2019: 5 · 2018: 1
- FWCI
- 4.68
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RISalud Institutional Health Repository of Andalucía (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- Institutional Repository of the University of Granada (University of Granada) (submittedVersion, cc-by-nc-nd)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by-nc-nd)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Universidad de Granada
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- insulin resistance, non-alcoholic fatty liver disease, hepatic triglyceride content, HOMA-IR, lean adults, overweight, waist circumference, body mass index, adiponectin, TNF-α, cardiometabolic risk factors, 1H NMR, type 2 diabetes
- MeSH terms
- Adult, Aged, Female, Humans, Liver, Male, Middle Aged, Triglycerides, Body Mass Index, Case-Control Studies, White People, Waist Circumference, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.